(Q40521510)

reason for preferred rank

21 September 2017

title

Maintenance therapy of adult acute nonlymphoblastic leukemia.An argument against the need for central nervous system prophylaxis (English)

1 reference

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

14 February 2023

Maintenance therapy of adult acute nonlymphoblastic leukemia: an argument against the need for central nervous system prophlyaxis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A272947

14 February 2023

1 reference

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

14 February 2023

author name string

J. O. Armitage

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A272947

14 February 2023

C. P. Burns

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A272947

14 February 2023

language of work or name

English

0 references

publication date

1 February 1978

1 reference

full work available at URL

21 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

1 reference

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

14 February 2023

1 reference

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

14 February 2023

1 reference

21 September 2017

volume

41

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

697-700

1 reference

Neurological Complications of Acute Leukemia in Adults: Changing Rate

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197802%2941%3A2%3C697%3A%3AAID-CNCR2820410240%3E3.0.CO%3B2-M

21 January 2018

Cancer Treatment Reports

1

60

585

Armitage

1976

1 reference

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

Remission maintenance of adult acute lymphoblastic leukemia

14 February 2023

2

1 reference

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

Treatment of central nervous system leukemia with intrathecal cytosine arabinoside

14 February 2023

3

1 reference

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

Treatment of acute leukemia in adults

14 February 2023

4

1 reference

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

Results of therapy in adult acute lymphocytic leukemia

14 February 2023

6

1 reference

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

Clinical pharmacology of l-β-D-arabinofuranosyl cytosine

14 February 2023

9

1 reference

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

MENINGEAL LEUKEMIA; A FOLLOW-UP STUDY.

14 February 2023

10

1 reference

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

Radiotherapy in leukemia and lymphoma of children

14 February 2023

11

1 reference

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

Neurotoxicity due to CNS therapy for leukemia

14 February 2023

12

1 reference

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

Combination chemotherapy of adult acute lymphocytic leukemia

14 February 2023

13

1 reference

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

14 February 2023

14

32

2023

Wiernik

1972

1 reference

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

The incidence of central nervous system leukemia in adults with acute leukemia

14 February 2023

16

1 reference

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C697::AID-CNCR2820410240%3E3.0.CO;2-M

14 February 2023

Identifiers

10.1002/1097-0142(197802)41:2<697::AID-CNCR2820410240>3.0.CO;2-M

1 reference

21 September 2017

1 reference